Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harris Upham was a prominent American stock brokerage and investment banking firm founded in the early 20th century. While the user suggested a potential link to life sciences, the company is historically recognized for its role in the financial services industry rather than biotechnology or healthcare. In 1976, the firm merged with Smith Barney to form Smith Barney, Harris Upham & Co., which eventually became part of Citigroup and later Morgan Stanley. The firm was known for its extensive network of retail brokerage offices and its participation in major underwriting syndicates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harris Upham.